Aminolevulinic Acid (ALA)
Aminolevulinic Acid (ALA) is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis
Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
Clinical Trials (7)
Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis
Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
Twelve Month Follow-Up of CP0108
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7